MyFinsight
Home
Blog
About
Contact
Sales and maturities
of marketable...
$113,354K
something is missing
$128,175K
Net cash provided by
investing activities
$66,310K
Net cash provided by
financing activities
$33,569K
Canceled cashflow
$47,044K
Canceled cashflow
$94,606K
Net decrease in
cash, cash...
-$17,467K
Canceled cashflow
$99,879K
Stock-based compensation
$13,479K
Operating lease
right-of-use assets
-$8,411K
Depreciation and
amortization
$2,202K
Change in fair value of
investments, net
-$904K
Accounts receivable
-$337K
Purchases of marketable
securities
$46,965K
Purchases of property and
equipment
$79K
Net proceeds from
issuance of common stock...
-$94,606K
Net cash used in
operating activities
-$117,346K
Canceled cashflow
$25,333K
Collaboration revenue
$15,048K
Interest income
$5,205K
Net loss
-$96,231K
Prepaid expenses and
other current assets
$12,972K
Operating lease
liabilities
-$12,840K
Canceled cashflow
$20,253K
Accrued expenses
-$11,947K
Deferred revenue
-$6,660K
Accounts payable
-$1,420K
Accretion of investment
discounts
$535K
Other assets
$74K
Research and development
$80,737K
General and
administrative
$34,843K
Other segment
information
$904K
Back
Back
Cash Flow
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)
source: myfinsight.com